The Bristol Myers Squibb Foundation, together with its partners, National Medical Fellowships and the American Association for Cancer Research, selected 52 physicians for its Diversity in Clinical Trials Career Development Program. These early-stage investigators are the first of 250 community-oriented clinical trialists who will be trained through the program by 2027.
J. Leonard Lichtenfeld joined SpotitEarly, an Israel-based technology company transforming cancer screening by harnessing the power of artificial intelligence and dogs to detect cancer early, as chief medical officer.
